New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A3 adenosine receptor antagonists

被引:44
作者
Baraldi, PG [1 ]
Preti, D
Tabrizi, MA
Fruttarolo, F
Romagnoli, R
Zaid, NA
Moorman, AR
Merighi, S
Varani, K
Borea, PA
机构
[1] Univ Ferrara, Dipartimento Sci Farmaceut, I-44100 Ferrara, Italy
[2] Univ Ferrara, Dipartimento Med Clin & Sperimentale, Sez Farmacol, I-44100 Ferrara, Italy
[3] King Pharmaceut R&D, Cary, NC 27513 USA
[4] An Najah Natl Univ, Coll Pharm, Nablus, Palestine, Israel
关键词
D O I
10.1021/jm058008c
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Compounds presenting an additional fused ring on the xanthine nucleus have been reported to exhibit antagonistic activity with various levels of affinity and selectivity toward the four adenosine receptors subtypes A(1) A(2A), A(2B), and A(3). This paper reports synthesis and biological evaluation of new 1-benzyl-3-propyl-IH,6H-pyrrolo[2,1-f]purine-2,4-diones and 1-benzyl-3propyl- 1H,8H-imidazo [2, 1-f] purine-2,4-diones, among which we identified potent and selective A(3) adenosine receptors antagonists. In particular, 1-benzyl-7-methyl-3-propyl-IH,8H-imidazo[2,1-f]purine-2,4-dione (11e) shows a K-i (hA(3)) value from binding assay of 0.8 nM.
引用
收藏
页码:4697 / 4701
页数:5
相关论文
共 31 条
[1]  
Avila MY, 2002, INVEST OPHTH VIS SCI, V43, P3021
[2]   Recent developments in the field of A3 adenosine receptor antagonists [J].
Baraldi, PG ;
Tabrizi, MA ;
Fruttarolo, F ;
Bovero, A ;
Avitabile, B ;
Preti, D ;
Romagnoli, R ;
Merighi, S ;
Gessi, S ;
Varani, K ;
Borea, PA .
DRUG DEVELOPMENT RESEARCH, 2003, 58 (04) :315-329
[3]   Synthesis, biological activity, and molecular modeling investigation of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as human A3 adenosine receptor antagonists [J].
Baraldi, PG ;
Cacciari, B ;
Moro, S ;
Spalluto, G ;
Pastorin, G ;
Da Ros, T ;
Klotz, KN ;
Varani, K ;
Gessi, S ;
Borea, PA .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (04) :770-780
[4]  
Baraldi PG, 2001, SYNTHESIS-STUTTGART, P773
[5]   New potent and selective human adenosine A3 receptor antagonists [J].
Baraldi, PG ;
Borea, PA .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (12) :456-459
[6]  
Borea PA, 2003, WO Patent, Patent No. 2004000224
[7]   Impact of the aryl substituent kind and distance from pyrimido[2,1-f]purindiones on the adenosine receptor selectivity and antagonistic properties [J].
Drabczynska, A ;
Schumacher, B ;
Müller, CE ;
Karolak-Wojciechowska, J ;
Michalak, B ;
Pekala, E ;
Kiec-Kononowicz, K .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2003, 38 (04) :397-402
[8]  
FISHMAN P, 2000, DRUG DEVELOP RES, V50, P101
[9]   Structure and function of adenosine receptors and their genes [J].
Fredholm, BB ;
Arslan, G ;
Halldner, L ;
Kull, B ;
Schulte, G ;
Wasserman, W .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2000, 362 (4-5) :364-374
[10]  
Fredholm BB, 2001, PHARMACOL REV, V53, P527